Ok. Lets try a different approach here. If,
Post# of 148173
If, as you say the cytokine storm is just avoiding the lungs, then how will this affect the endpoints of our trial?
Will it:
1) have no bearing
2) improve our chances of hitting our primary endpoint
3) reduce our chances of hitting our primary endpoint
Look, I was overly confident with CD12 and now I am looking for all possibilities.
You can call it showing my true colors if that makes you feel better. Your opinion of me is meaningless.